News
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Tarkett - Information on the total number of voting rights and shares in Tarkett’s share capital as of November, 30th, 2024
Tarkett Group announces total voting rights and shares information as of November 30, 2024, in compliance with regulations. Tarkett is a global leader in flooring solutions -
COMMUNIQUÉ DE PRESSE
Tarkett - Information relative au nombre total des droits de vote et d’actions composant le capital social de Tarkett au 30 novembre 2024
Communiqué de presse sur le nombre total des droits de vote et d'actions de Tarkett Groupe au 30 novembre 2024. Tarkett, leader mondial des revêtements de sol durables, réalise un CA de 3,4M€ -
COMMUNIQUÉ DE PRESSE
IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology
IGC Pharma, Inc. expands clinical research program for IGC-AD1, an investigational treatment for Alzheimer's disease, to evaluate disease-modifying potential targeting amyloid plaque and tau tangles
